Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Jonah Whanau @Jonah Whanau
Bronze member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative technical analysis

Market capitalization:

$8,484,323talents

Virtual portfolio value:

$5,352,563talents

Net overall return per annum:

19.34%

AYA current rank order:

#5

Asset investment philosophy:
Jonah Whanau trades U.S. stocks with the top #326 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 65,309 +681.13% $235,765
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 3,446 +589.24% $141,527
NTZ Natuzzi S.p.A. $2.21 $11.92 10,868 +439.37% $105,528
MPWR Monolithic Power Systems Inc. Common Stock $85.91 $392.24 279 +356.57% $85,466
SNPS Synopsys Inc. Common Stock $65.98 $286.79 364 +334.66% $80,375
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 10,516 +2,108.33% $79,816
MED MEDIFAST INC Common Stock $43.80 $178.36 548 +307.21% $73,739
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 123,283 +475.00% $70,271
MRNS Marinus Pharmaceuticals Inc. Common Stock $1.94 $11.62 2,646 +498.97% $25,613
BBX BBX Capital Corporation $2.54 $14.54 1,682 +472.44% $20,184
Sum $918,284

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
NVCT Nuvectis Pharma Inc. Common Stock $27.19 3,373 $91,711
QURE uniQure N.V. Ordinary Shares $47.51 1,152 $54,731
AMAT Applied Materials Inc. Common Stock $626.84 73 $45,759
TECH Bio-Techne Corp Common Stock $71.00 636 $45,156
MGNI Magnite Inc. Common Stock $18.73 2,294 $42,966
LGND Ligand Pharmaceuticals Incorporated Common Stock $303.59 141 $42,806
HIMS Hims & Hers Health Inc. Class A Common Stock $33.94 1,257 $42,662
WRLD World Acceptance Corporation Common Stock $213.77 199 $42,540
TCI Transcontinental Realty Investors Inc. Common Stock $49.85 848 $42,272
TRVI Trevi Therapeutics Inc. Common Stock $18.15 2,325 $42,198
Sum $492,801

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$PSX

Blog+More

Platform enterprises leverage network effects, scale economies, and information cascades to boost exponential user growth.

Fiona Sydney

2020-05-28 15:37:00 Thursday ET

Platform enterprises leverage network effects, scale economies, and information cascades to boost exponential user growth.

Platform enterprises leverage network effects, scale economies, and information cascades to boost exponential business growth. Laure Reillier and Benoit

+See More

President Trump's current trade policies appear like the Reagan administration's protectionist trade policies back in the 1980s.

Apple Boston

2018-07-03 11:42:00 Tuesday ET

President Trump's current trade policies appear like the Reagan administration's protectionist trade policies back in the 1980s.

President Trump's current trade policies appear like the Reagan administration's protectionist trade policies back in the 1980s. In comparison to th

+See More

Andy Yeh Alpha (AYA) fintech network platform: major milestones, key product features, and online social media services

Joseph Corr

2026-01-19 10:30:00 Monday ET

Andy Yeh Alpha (AYA) fintech network platform: major milestones, key product features, and online social media services

  Andy Yeh Alpha (AYA) fintech network platform: major milestones, key product features, and online social media services   Introduction

+See More

Disruptive innovators compete against luck by figuring out why customers hire products and services to accomplish specific jobs.

John Fourier

2020-05-14 12:35:00 Thursday ET

Disruptive innovators compete against luck by figuring out why customers hire products and services to accomplish specific jobs.

Disruptive innovators can better compete against luck by figuring out why customers hire products and services to accomplish jobs. Clayton Christensen, T

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

The Trump administration blames China for egregious currency misalignment.

Olivia London

2018-10-17 12:33:00 Wednesday ET

The Trump administration blames China for egregious currency misalignment.

The Trump administration blames China for egregious currency misalignment, but this criticism cannot confirm *currency manipulation* on the part of the Chin

+See More